Results 151 to 160 of about 4,984,276 (289)

Can somatic GATA2 mutation mimic germ line GATA2 mutation? [PDF]

, 2018
Somatic GATA2 mutation is associated with immunodeficiency and pulmonary alveolar proteinosis in a patient with myeloproliferative ...
Collin, M, Dickinson, R, Lipman, M, Lowe, D, Marafioti, T, Mitchell, C, Pocock, R, Sekhar, M   +7 more
core  

Fibrocytes in primary myelofibrosis

Oncotarget, 2021
Shimoda, Kazuya, Ozono, Yoshinori, Shide, Kotaro   +2 more
openaire   +2 more sources

Massive bone marrow necrosis and postnecrotic myelofibrosis in a patient with primary thrombocythaemia. [PDF]

, 1994
Gautam Majumdar, J. Phillips, Thomas C. Pearson   +2 more
openalex   +1 more source

CONTEMPORARY APPROACH IN THE DIAGNOSIS AND MANAGEMENT OF PRIMARY MYELOFIBROSIS

, 2021
Irena Ćojbašić
openalex   +1 more source

PB2251: SOMETIMES IT’S ZEBRAS: SUCCESSFUL TREATMENT OF ERYTHROPOIETIC PROTOPORPHYRIA POST PRIMARY MYELOFIBROSIS WITH GIVOSIRAN - A CASE REPORT

, 2023
Alina Cătană, Geanina Mera, Cristina Popa   +2 more
openalex   +1 more source

Clinical features and treatment of newly diagnosed multiple myeloma with secondary myelofibrosis: a retrospective study

Therapeutic Advances in Hematology
Background: Secondary myelofibrosis (SMF) is characterized by the excessive deposition of fibrous tissue on top of the primary disease, often causing clinical manifestations to be overshadowed by the primary disease.
Han Xu, Yujie Xu, Mengying Wang, Chunxia Mao, Junxia Huang, Tianlan Li, Yan Gao, Shanshan Liu, Jingjing Zhou, Yi Zhang, Xianqi Feng   +10 more
doaj   +1 more source

MESENCHYMAL STEM CELLS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: IDLE OBSERVERS OR PART OF THE DISEASE? [PDF]

, 2019
Accurso, V., Cordova, A., Di Piazza, F., Di Stefano, A. B., Lo Re, J., Mancuso, S., Russo, A., Santoro, M., Siragusa, S.   +8 more
core   +1 more source

JAK-2 inhibitors and allogeneic transplant in myelofibrosis [PDF]

, 2015
7The activation of the JAK1/JAK2 pathway plays a crucial role in the pathogenesis of myelofibrosis. Treatment with the JAK2 inhibitor ruxolitinib demonstrated to reduce splenomegaly and symptoms in patients affected by myelofibrosis, leading to a ...
Cigana, C, De Marchi, R, Fanin, Renato, Lazzarotto, D, Patriarca, Francesca, Perali, G, Sperotto, A   +6 more
core  

Platelet-derived growth factor receptor [béta] (PDGFR[béta]) immunohistochemistry highlights activated bone marrow stroma and is potentially predictive for fibrosis progression in prefibrotic myeloproliferative neoplasia [PDF]

, 2017
Anagnostopoulos, Ioannis, Bedekovics, Judit, Hebeda, Konnie, Krenács, László, Méhes, Gábor, Tzankov, Alexandar   +5 more
core   +1 more source

Supplemental Table S1 from Osteogenic Potential of Mesenchymal Stromal Cells Contributes to Primary Myelofibrosis

, 2023
Christophe Martinaud, Christophe Desterke, Johanna Konopacki, Lisa Pieri, Fréderic Torossian, Rachel Golub, Sandrine Schmutz, Adrienne Anginot, Bernadette Guerton, Nathalie Rochet, Patricia Albanese, Emilie Hénault, Olivier Pierre-Louis, Jean-Baptiste Souraud, Thierry de Revel, Brigitte Dupriez, Jean‐Christophe Ianotto, Marie‐Françoise Bourgeade, Alessandro M. Vannucchi, Jean‐Jacques Lataillade, Marie‐Caroline Le Bousse‐Kerdilès   +20 more
openalex   +1 more source